Hematologic complications in patients exposed to poly-ADP ribose polymerase inhibitors

Read full text
Authors: Joseph Cannova, Muriel R. Battaglia, Gregory W. Roloff, Sinan Cem Cetin, Michael Tallarico, Wendy Stock, Anand Ashwin Patel, Olatoyosi M. Odenike, Richard A. Larson, Michael J. Thirman, Mariam T. Nawas, Peng Wang
+5 more Melissa Yuwono Tjota, Jeremy P. Segal, Girish Venkataraman, Adam S. DuVall, Michael William Drazer
Cited by: 0

Fields of Study & Subjects

PARP inhibition in cancer therapy Chronic Lymphocytic Leukemia Research Blood disorders and treatments

Publication details

Journal / source
Haematologica
Volume
111
Issue
7
Pages
2451–2456
Publication date
29 January 2026
Language
EN